Gregory W. Schafer, Chief Operating Officer at ADURO BIOTECH, INC. (ADRO), sold 20,000 shares at $7.97 ($159K) on 2017-11-06, disclosed to the SEC on 2017-11-08.
Scheduled sale ($159k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ADRO | SELL | 2017-10-04 | $215K | — | Filing → |
| ADRO | SELL | 2017-09-14 | $53K | — | Filing → |
| ADRO | SELL | 2017-09-06 | $234K | — | Filing → |